|
Memphis Pharmaceuticals unaudited results for H1 09/10 hit EGP 8.3m
|
|
Memphis Pharmaceuticals announced in statement sent to EGX that the unaudited results for the period from 1/7/2009 to 31/12/2009 recorded EGP 8.316 million compared to net loss of EGP 16.018 million for the period from 1/7/2008 to 31/12/2008, noting that this losses was a result of settlements worth EGP 18.632 million related to 2007/2008 financial year. The reported profits for the first half of 2009/2010 is under review by the Central Auditing Organization.
|
| Time Added : 2010-02-08 15:45:16 |
Source :
|
|
|
|
